CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Daptomycindrug
Likely dose
Daptomycin 5 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01012089
NCT01012089N/ACompleted
CompareCT.gov

Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease

University of Oklahoma·interventional·Posted Nov 11, 2009·Updated Jun 6, 2018

In Brief

A clinical study evaluating Daptomycin for Chronic Kidney Disease and Bacterial Infection. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease, Bacterial Infection
CountriesUnited States
CollaboratorsCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 11, 2009
Enrollment StartNov 1, 2009
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 16.6 years ago

Interventions

Daptomycindrug

Daptomycin IV 5 mg/kg one time dose